Post-ERCP Pancreatitis: Prevention, Diagnosis and Management

Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis (PEP) rate of 2–10%, which could be as high as 30–50% in high-risk cases. PEP is severe in up to 5% of cases, with potential for life-threatening complications, including multi-organ failure, peripancreatic fluid...

Descripción completa

Detalles Bibliográficos
Autores principales: Cahyadi, Oscar, Tehami, Nadeem, de-Madaria, Enrique, Siau, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502657/
https://www.ncbi.nlm.nih.gov/pubmed/36143938
http://dx.doi.org/10.3390/medicina58091261
_version_ 1784795760893624320
author Cahyadi, Oscar
Tehami, Nadeem
de-Madaria, Enrique
Siau, Keith
author_facet Cahyadi, Oscar
Tehami, Nadeem
de-Madaria, Enrique
Siau, Keith
author_sort Cahyadi, Oscar
collection PubMed
description Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis (PEP) rate of 2–10%, which could be as high as 30–50% in high-risk cases. PEP is severe in up to 5% of cases, with potential for life-threatening complications, including multi-organ failure, peripancreatic fluid collections, and death in up to 1% of cases. The risk of PEP is potentially predictable and may be modified with pharmacological measures and endoscopist technique. This review covers the definition, epidemiology and risk factors for PEP, with a focus on the latest evidence-based medical and endoscopic strategies to prevent and manage PEP.
format Online
Article
Text
id pubmed-9502657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95026572022-09-24 Post-ERCP Pancreatitis: Prevention, Diagnosis and Management Cahyadi, Oscar Tehami, Nadeem de-Madaria, Enrique Siau, Keith Medicina (Kaunas) Review Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis (PEP) rate of 2–10%, which could be as high as 30–50% in high-risk cases. PEP is severe in up to 5% of cases, with potential for life-threatening complications, including multi-organ failure, peripancreatic fluid collections, and death in up to 1% of cases. The risk of PEP is potentially predictable and may be modified with pharmacological measures and endoscopist technique. This review covers the definition, epidemiology and risk factors for PEP, with a focus on the latest evidence-based medical and endoscopic strategies to prevent and manage PEP. MDPI 2022-09-12 /pmc/articles/PMC9502657/ /pubmed/36143938 http://dx.doi.org/10.3390/medicina58091261 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cahyadi, Oscar
Tehami, Nadeem
de-Madaria, Enrique
Siau, Keith
Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
title Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
title_full Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
title_fullStr Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
title_full_unstemmed Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
title_short Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
title_sort post-ercp pancreatitis: prevention, diagnosis and management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502657/
https://www.ncbi.nlm.nih.gov/pubmed/36143938
http://dx.doi.org/10.3390/medicina58091261
work_keys_str_mv AT cahyadioscar postercppancreatitispreventiondiagnosisandmanagement
AT tehaminadeem postercppancreatitispreventiondiagnosisandmanagement
AT demadariaenrique postercppancreatitispreventiondiagnosisandmanagement
AT siaukeith postercppancreatitispreventiondiagnosisandmanagement

Ejemplares similares